INTRODUCTION
With a finished reference sequence in hand and the construction of a haplotype map well underway (1) , whole genome association studies of disease risk and drug response in humans are now within reach. It is estimated that 300,000 to 1,000,000 single nucleotide polymorphisms (SNPs) will be required to tag all common haplotypes (2, 3) . However, highly powered association studies (sample size above 2000) remain prohibitively expensive at the genome level, despite the recent development of highly multiplexed genotyping technologies, which have brought about a substantial reduction in individual genotyping cost.
Risch et al. (4) proposed a two-step approach for conducting association studies. First, pooled DNA samples are used to obtain allele frequency estimates for all SNP markers in both cases and controls, which allows the identification of putative regions of association. Then, individual markers are typed to confirm association and determine the diseasecausing variants (4) . Several methods have been described for obtaining SNP allele frequency estimates from pooled DNA samples (5) (6) (7) (8) (9) (10) .
The assessment of variance in obtained allele frequency estimates describes quantitative errors introduced at stages of the experimental procedure utilized (11) (12) (13) . Previously, variance components of all steps have been estimated using Pyrosequencing™ (Biotage AB, Uppsala, Sweden), and the effective sample size and the costefficiency of different study designs were assessed (14) . Based on these results, the use of multiple small pools (50 individuals per pool) with no replication of experimental steps was suggested as the most cost-efficient and statistically powerful pooling strategy. In this study, we assessed a different method for SNP allele frequency estimation that is based on the homogeneous mass extend (HME) assay, with analysis using matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry (7, 13, 15, 16) , and performed a variance components analysis using data from replicates in each step (i.e., pool formation, PCR/primer extension, and allele frequency estimation). With these variance components, the relative sample size and cost-efficiency of different experimental designs using this genotyping platform are considered. were averaged to give the concentration of each sample (this was repeated if two or more readings gave a standard deviation of more than 5% of the mean value). These concentrations were then used to dilute a fresh aliquot of each sample to 25 ng/μL. Each individual formed the following set of pools: 1 × 240, 2 × 120, and 4 × 60 samples, constituting 21 pools in total. Pools contained 10 μL of each of the corresponding samples. In addition, a separate aliquot of each sample was diluted to 3.5 ng/μL for individual genotyping.
MATERIALS AND METHODS

Samples and SNPs
DNA
Allele Frequency Estimation
SNP assays were designed with the SpectroDESIGNER™ software, and SNP typing was performed using the MassARRAY™ platform (Sequenom, Hamburg, Germany). PCR amplification of individual and pooled samples was performed in 5-μL reactions using 3.5 and 25 ng DNA and 150 and 200 nM of each forward and reverse primer, respectively, 200 μM dNTPs, 1× PCR buffer, and 0.04 U HotStarTaq ® polymerase (HotStarTaq Master Mix Kit; Qiagen, Valencia, CA, USA). Cycling conditions were 94°C for 15 min, followed by 45 cycles of 94°C for 20 s, 56°C for 30 s, and 72°C for 1 min, and then 72°C for 3 min. PCR products were treated with 2 μL of 0.5 U/μL shrimp alkaline phosphatase (USB, Cleveland, OH, USA) in 1.9 mM MgCl 2 for 20 min at 37°C, followed by 5 min at 80°C. Primer extension was performed in 9-μL reactions containing a final concentration of 0.556 μM extend primer (Sigma-Genosys Ltd., Haverhill, UK), 50 μM each ddNTP and dNTP, Thermo Sequenase ® buffer (Amersham Biosciences, Uppsala, Sweden), pH 9.5, to give 5.8 mM Tris-HCl and 1.4 mM MgCl 2 , and 0.064 U Thermo Sequenase DNA polymerase (Amersham Biosciences). Cycling conditions were 2 min at 94°C, followed by 94°C for 5 s, 52°C for 5 s, and 72°C for 5 s (55 and 45 cycles for individual and pooled samples, respectively). The samples were desalted with 3 mg SpectroCLEAN™ resin (Sequenom), and an aliquot (four aliquots for pooled samples) was transferred to a matrix pad of a 384-well chip (SpectroCHIP™ 384 and SpectroCHIP A384 for individual and pooled samples, respectively; Sequenom). The laser of the MALDI-TOF Mass Spectrometer (BIFLEX™; Bruker Daltonics, Billerica, MA, USA) fired at five different areas of each matrix pad; good spectra were stored and analyzed with MassARRAY quantitative gene analysis software.
Estimation of Variance Components, Relative Sample Size, and Cost-Efficiency
Estimates of the variance components in pool formation (σ 2 for ), PCR/ HME (σ 2 pcr/hme ), and allele frequency estimation (σ 2 est ) were calculated from uncorrected data with the restricted maximum likelihood (REML) method (17) . The effective sample size (N*) at a given allele frequency, q, was calculated using the means of these variance components. The relative sample size (RSS) can be expressed as the ratio of N* to the true sample size N (i.e., obtained by individual genotyping). Costefficiency (CE) can be estimated as the ratio of RSS.C i :C p , where C i and C p are the costs based on individual and pooled genotyping, respectively (14) . In this study, experimental component costs (including reagents and labor) were estimated at pool formation, c quant = 60; PCR/HME, c pcr/hme = 21; and allele frequency estimation, c est = 67. Each pool contained sufficient DNA for typing 5000 SNPs. Individual typing costs (4-plex) were estimated at PCR/HME c i-pcr/hme = 5.25 and genotype acquisition c i-gen = 8.75 . N* can be calculated using the formula below, assuming no relationship between variance and allele frequency (14) 
RESULTS
Individual typing of the 240 DNA samples with 8 SNPs was carried out using the HME and the 5′ nuclease TaqMan ® (ABI Prism ® 7000 sequence detection system; Applied Biosystems, Foster City, CA, USA) assays. The concordance rate between the two platforms was 99.95% (1920 comparisons). We used the 240 DNA samples to prepare 7 pools (1 × s p = 240, 2 × s p =120, 4 × s p = 60) in triplicate; pooled samples were typed using the HME assay. The uncorrected allele frequency estimates obtained were adjusted (corrected) using allele peak area ratios of spectra acquired with both heterozygote and homozygote individuals (corrects for any allelic imbalance introduced by an SNP assay).
Corrected allele frequency estimates showed a mean discrepancy of ±0.021 when compared to the allele frequency calculated from individual typings and a discrepancy range from 0.000 to 0.069 (Table 1) .
We then used uncorrected allele frequency data to estimate the variance components related to each of the three experimental steps examined, pool formation, PCR/HME, and allele frequency estimation; the estimated variance was σ 2 for = 4.88 × 10 -6 , σ 2 pcr/hme = 4.68 × 10 -5 , and σ 2 est = 1.77 × 10 -4 , respectively. These figures were then applied in a hypothetical association study design with no replication and single pools of 500 case and 500 control samples (N = 500) to calculate the RSS and CE parameters for markers of different allele frequencies, q ( Figure 1) ; for example, CE = 35.6 and RSS = 0.48 at q = 0.3. Experimental error is expected to decrease (increased RSS as a result) by introducing experimental replication or creating a number of subpools. Note that both approaches are at the expense of cost-efficiency. For example, replicating the pool formation five times, R for = 5, increased the RSS to 0.82 and reduced CE to 12.2. Similarly, creating subpools of 100 samples per pool also resulted in an RSS of 0.82, but with a slightly higher CE of 12.9. Notably, as N is increased, subpool formation is more cost-efficient than pool replication.
The above calculations assume no relationship between variance and pool size, allele frequency, or SNP assay. The observed variance component estimates showed no relationship to either pool size or SNP assay. However, all three variance components appeared to be approximately proportional to q(1 -q) (Figure 2 ). Assuming this relationship, the calculation for RSS can be modified to replace the variance components by k stage q (1 -q) . Therefore, the factor q(1 -q) in the denominator and the numerator cancel, and estimates of RSS and, therefore, CE, become independent of allele frequency (denoted by RSSq and CEq). The constants calculated from our experimental data were: pool formation, k for = 6.92 × 10 -5 ; PCR/HME, k pcr/hme = 2.97 × 10 -4 , and allele frequency estimation, k est = 1.71 × 10 -3 . When we applied these constants to the hypothetical association study described above (N = 500, single pools of case and control samples and no replication), we found RSSq = 0.32 and CEq = 24.2, irrespective of allele frequency. As before, RSSq increased as either the number of replicate pool formations or the number of subpools increased (Figure 3) . Increasing the number of replicate pool formations was less cost-efficient than increasing the number of subpools (Figure 3) . The larg- 
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er the sample size, the more pronounced this effect is; for example, with N = 1000 and RSSq = 0.71, 10 replicate pool formations give a CEq = 9.9, whereas 10 subpools give a CEq = 11.1.
DISCUSSION
We assessed three steps of the Mass-ARRAY platform, including pool formation, PCR/HME, and allele frequency estimation, the mean variance observed at each step were σ 2 for = 4.88 × 10 -6 , σ 2 pcr/hme = 4.68 × 10 -5 , and σ 2 est = 1.77 × 10 -4 (assuming no relationship between experimental error and allele frequency). These figures are 22-, 6-, and 3-fold lower than those obtained with the Pyrosequencing platform (14) . The mean discrepancy in allele frequency estimates was comparable between the two studies, ±0.019 and ±0.021 (this study). The reduction in variance may be due to one (or a combination) of several experimental factors. For example, for the threshold in DNA quantification, we used an sd ≤ 5% of the mean value between three possible measurements rather than sd ≤ 20% of the mean of two values.
Under the assumption that variance is not correlated with allele frequency, the values of RSS and CE are dependent on the allele frequency of the marker studied. However, our data suggest that at lower allele frequencies the variance may be reduced, leading to estimates of RSS and CE that are allele frequency independent (RSSq and CEq). Estimated variance components and the RSSq and CEq calculations can be used to assist the design of powerful We have shown that the use of small (50-100 individuals) subpools is more cost-efficient than the replication of experimental steps. The calculation of CE assumes that the cost of forming a pool is equal to the cost of measuring the concentration of all samples in the case and control pools, divided by the attempted number of marker typings per pool. Note that the labor factor in forming replicate pools is far greater than forming one set of subpools and thus impacts directly on the cost. In addition, due to dead-volumes in pipeting the use of, for example, 10 subpools with 100 samples in each one requires 10-fold less DNA compared to 10 replicates of one pool with 1000 samples (assumes the same RSSq in each case). However, the selected size in subpool formation does affect the RSSq and CEq ( Figure 4) ; pooling study design will require setting a threshold for RSSq, keeping in mind that the number of samples per subpool impacts the overall sample size required if the association were to be assessed by a two-sample t-test.
Our data suggest that there may be a relationship between variance and marker allele frequency. Interestingly, under this assumption, both RSSq and CEq are independent of marker allele frequency ( Figure 5 ). This implies that even markers with low allele frequencies can be used in pooling experiments without excessive loss of power relative to individual genotyping.
With careful study design and a suitable allele frequency estimation platform, pooling is an attractive, costefficient, labor-efficient, and DNA-efficient option to enable whole genome association studies.
